FILTRIX Logo FILTRIX Find Your Edge →

Biological Products, (No Disgnostic Substances) Stocks

SIC 2836 | 129 tickers analyzed | 3,622 total alerts

📊
129
Tickers
🔔
3,622
Total Alerts
🎯
44.0%
Avg Win Rate
💰
-0.52%
Avg Gain

📈 Sector Performance by Timeframe

5-Minute

Avg Gain: -0.39%
Win Rate: 40.0%

15-Minute

Avg Gain: -0.58%
Win Rate: 41.3%

30-Minute

Avg Gain: -0.59%
Win Rate: 41.5%

60-Minute

Avg Gain: -0.77%
Win Rate: 42.2%

EOD

Avg Gain: -0.29%
Win Rate: 55.2%

MFE/MAE

Avg MFE: +6.75%
Avg MAE: -2.78%

📋 Biological Products, (No Disgnostic Substances) Stocks (100)

All tickers in SIC 2836 with Trade-Ideas alert data, sorted by alert count.

# Ticker Company Market Cap Alerts Avg Win Rate Avg 5min MFE Action
1 DNA Ginkgo Bioworks Holdings, Inc. $607.1M 436 43.2% -0.59% +4.00% View →
2 OCGN Ocugen, Inc. Common Stock $543.4M 332 38.4% -0.63% +3.63% View →
3 NVAX Novavax Inc $1.49B 312 44.0% -0.27% +5.20% View →
4 MRNA Moderna, Inc. Common Stock $19.03B 173 50.0% +0.07% +3.82% View →
5 RXRX Recursion Pharmaceuticals, Inc. Class A Common Stock $2.46B 147 44.8% -0.46% +4.58% View →
6 GILD Gilead Sciences Inc $168.65B 138 57.2% +0.10% +1.26% View →
7 PALI Palisade Bio, Inc. Common Stock $285.0M 118 42.1% -0.18% +9.75% View →
8 OTLK Outlook Therapeutics, Inc. Common Stock $32.2M 84 53.8% -0.01% +10.10% View →
9 AMGN Amgen Inc $185.64B 82 53.4% +0.03% +1.16% View →
10 IBRX ImmunityBio, Inc. Common Stock $6.35B 79 44.6% -0.97% +9.39% View →
11 SGMO Sangamo Therapeutics, Inc. Common Stock $127.7M 75 44.8% +0.12% +9.76% View →
12 PLX Protalix BioTherapeutics, Inc. Common Stock $167.3M 64 44.7% -0.23% +4.59% View →
13 IOVA Iovance Biotherapeutics, Inc. Common Stock $1.05B 63 43.5% -0.33% +4.85% View →
14 XFOR X4 Pharmaceuticals, Inc. Common Stock $323.5M 57 38.2% -1.96% +8.62% View →
15 SNTI Senti Biosciences, Inc. Common Stock $28.4M 57 42.1% -0.80% +17.26% View →
16 CELZ Creative Medical Technology Holdings, Inc. Common Stock $7.3M 51 42.2% -0.16% +9.61% View →
17 CHRS Coherus Oncology, Inc. Common Stock $249.0M 47 42.1% -0.37% +6.39% View →
18 TVGN Tevogen Bio Holdings Inc. Common Stock $69.5M 44 35.0% -0.26% +12.36% View →
19 BIIB Biogen Inc. Common Stock $25.17B 43 43.7% -0.38% +1.24% View →
20 ATRA Atara Biotherapeutics, Inc $37.6M 41 59.6% +0.56% +11.12% View →
21 CGTX Cognition Therapeutics, Inc. Common Stock $126.2M 40 38.5% -0.94% +8.30% View →
22 DBVT DBV Technologies S.A. $1.33B 39 45.5% -0.03% +6.61% View →
23 AGEN Agenus Inc. $117.1M 39 51.3% -0.53% +5.35% View →
24 CRIS Curis Inc $12.1M 33 35.2% -0.96% +6.76% View →
25 TSHA Taysha Gene Therapies, Inc. Common Stock $1.28B 32 39.4% -0.56% +9.76% View →
26 TNYA Tenaya Therapeutics, Inc. Common Stock $158.1M 30 38.7% -0.48% +7.07% View →
27 SLXN Silexion Therapeutics Corp Ordinary Shares $6.8M 30 42.7% -1.23% +12.55% View →
28 SCLX Scilex Holding Company Common Stock $77.3M 29 44.8% -0.75% +7.03% View →
29 INAB IN8bio, Inc. Common Stock $23.4M 29 42.0% -0.66% +10.13% View →
30 SLDB Solid Biosciences Inc. Common Stock $514.2M 25 54.4% -0.46% +9.05% View →
31 HUMA Humacyte, Inc. Common Stock $202.6M 25 44.8% -0.39% +7.22% View →
32 BCRX BioCryst Pharmaceuticals Inc $1.43B 25 60.0% -0.21% +6.68% View →
33 CADL Candel Therapeutics, Inc. Common Stock $340.4M 24 49.9% +1.30% +15.67% View →
34 DTIL Precision BioSciences, Inc. Common Stock $101.1M 24 42.0% -0.70% +4.55% View →
35 BCDA BioCardia, Inc. Common Stock $14.2M 23 37.3% -0.08% +8.59% View →
36 CRSP CRISPR Therapeutics AG $5.29B 23 47.8% -0.34% +4.61% View →
37 CCCC C4 Therapeutics, Inc. $208.4M 23 57.4% +0.93% +16.24% View →
38 CVM Cel-Sci Corporation $49.0M 23 44.3% +0.39% +14.95% View →
39 CRDF Cardiff Oncology, Inc. Common Stock $195.3M 22 39.4% +1.06% +9.83% View →
40 BDTX Black Diamond Therapeutics, Inc. Common Stock $148.7M 20 24.0% -1.25% +6.13% View →
41 IVVD Invivyd, Inc. Common Stock $595.0M 20 40.0% -1.59% +21.23% View →
42 JSPR Jasper Therapeutics, Inc. Common Stock $43.9M 20 51.0% +0.37% +17.19% View →
43 AIM AIM ImmunoTech Inc. $3.5M 19 35.1% -0.19% +5.34% View →
44 IKT Inhibikase Therapeutics, Inc. Common Stock $211.0M 17 38.5% -0.97% +8.23% View →
45 CABA Cabaletta Bio, Inc. Common Stock $306.1M 16 33.8% -1.14% +12.54% View →
46 CRBU Caribou Biosciences, Inc. Common Stock $143.0M 16 30.0% -1.02% +4.77% View →
47 CLDI Calidi Biotherapeutics, Inc. $7.3M 15 30.7% -2.21% +13.97% View →
48 PHGE BiomX Inc. $6.1M 15 49.7% +0.08% +11.53% View →
49 SANA Sana Biotechnology, Inc. Common Stock $1.29B 14 45.7% +1.47% +8.65% View →
50 ADMA ADMA Biologics, Inc. $3.98B 14 57.1% +0.27% +6.88% View →
51 ALGS Aligos Therapeutics, Inc. Common Stock $50.0M 14 45.4% -2.25% +8.20% View →
52 QNCX Quince Therapeutics, Inc. Common Stock $171.5M 14 26.2% -2.24% +7.08% View →
53 NBIX Neurocrine Biosciences Inc $13.58B 14 65.7% +0.14% +1.75% View →
54 EDIT Editas Medicine, Inc. Common Stock $210.9M 13 43.1% -0.94% +6.19% View →
55 BCAB BioAtla, Inc. Common Stock $22.6M 13 26.5% -1.38% +8.39% View →
56 AVXL Anavex Life Sciences $470.0M 13 23.1% -1.47% +5.25% View →
57 IMVT Immunovant, Inc. Common Stock $5.24B 12 56.7% +0.71% +8.78% View →
58 SABS SAB Biotherapeutics, Inc. Common Stock $192.3M 12 42.7% -2.22% +14.60% View →
59 VIR Vir Biotechnology, Inc. Common Stock $1.05B 12 25.0% -1.46% +4.22% View →
60 SRZN Surrozen, Inc. Common $168.0M 11 54.0% -0.50% +14.11% View →
61 KOD Kodiak Sciences Inc Common Stock $1.58B 11 60.0% +0.02% +13.78% View →
62 HALO Halozyme Therapeutics, Inc. $8.14B 10 30.2% -1.07% +1.45% View →
63 FDMT 4D Molecular Therapeutics, Inc. Common Stock $454.8M 10 32.0% -2.37% +6.07% View →
64 LCTX Lineage Cell Therapeutics, Inc. $370.8M 10 20.4% -0.71% +3.29% View →
65 ABOS Acumen Pharmaceuticals, Inc. Common Stock $119.9M 10 28.0% -0.70% +8.74% View →
66 NMRA Neumora Therapeutics, Inc. Common Stock $350.1M 10 61.3% +0.65% +8.94% View →
67 TCRX TScan Therapeutics, Inc. Common Stock $64.7M 10 53.1% +0.22% +25.40% View →
68 RVMD Revolution Medicines, Inc. Common Stock $22.74B 9 51.1% -2.20% +4.88% View →
69 FATE Fate Therapeutics, Inc. $139.6M 9 55.6% +3.69% +14.54% View →
70 AUTL Autolus Therapeutics plc American Depositary Share $388.6M 8 22.5% -0.53% +3.79% View →
71 ALLO Allogene Therapeutics, Inc. Common Stock $386.5M 8 27.5% +0.55% +6.56% View →
72 BEAM Beam Therapeutics Inc. Common Stock $3.20B 8 55.0% +0.14% +8.05% View →
73 TECH Bio-Techne Corp. $10.62B 8 47.9% -0.00% +1.24% View →
74 RLAY Relay Therapeutics, Inc. Common Stock $1.29B 8 42.5% +0.17% +8.40% View →
75 EXEL Exelixis Inc $11.87B 7 65.7% -0.11% +1.54% View →
76 PCVX Vaxcyte, Inc. Common Stock $6.90B 7 51.4% +0.64% +6.08% View →
77 PMCB PharmaCyte Biotech, Inc. Common Stock $9.5M 7 20.0% -0.30% +2.05% View →
78 PASG Passage Bio, Inc. Common Stock $40.0M 7 65.7% +0.12% +14.14% View →
79 DNLI Denali Therapeutics Inc. Common Stock $3.16B 6 33.3% -1.06% +4.83% View →
80 SCNI Scinai Immunotherapeutics Ltd. American Depositary Shares $3.5M 6 27.3% +2.64% +10.82% View →
81 INBX Inhibrx Biosciences, Inc. Common Stock $1.09B 6 64.7% +0.47% +6.34% View →
82 STRO Sutro Biopharma, Inc. $128.2M 6 36.7% -1.31% +6.30% View →
83 ZURA Zura Bio Limited Class A Ordinary Shares $413.5M 6 43.3% -0.10% +16.82% View →
84 TIL Instil Bio, Inc. Common Stock $48.4M 6 60.0% +0.68% +5.13% View →
85 TWST Twist Bioscience Corporation Common Stock $2.63B 6 36.7% -0.76% +4.84% View →
86 ENTX Entera Bio Ltd. Ordinary Shares $73.4M 6 28.0% -0.96% +9.40% View →
87 SRRK Scholar Rock Holding Corporation Common Stock $4.52B 5 32.0% +0.26% +9.98% View →
88 REPL Replimune Group, Inc. $604.8M 5 68.0% -1.10% +7.54% View →
89 VOR Vor Biopharma Inc. Common Stock $642.4M 5 52.0% +2.16% +23.07% View →
90 ACLX Arcellx, Inc. Common Stock $3.91B 5 28.0% -1.21% +4.45% View →
91 MGX Metagenomi Therapeutics, Inc. Common Stock $63.5M 5 40.0% +3.16% +23.51% View →
92 KLTO Klotho Neurosciences, Inc. Common Stock $23.7M 4 20.0% +0.45% +10.33% View →
93 CGEM Cullinan Therapeutics, Inc. Common Stock $738.5M 4 15.0% -1.77% +2.69% View →
94 CMPX Compass Therapeutics, Inc. Common Stock $1.05B 4 25.0% -2.00% +18.76% View →
95 ELUT Elutia Inc. Class A Common Stock $40.6M 4 60.0% +0.88% +18.35% View →
96 TARS Tarsus Pharmaceuticals, Inc. Common Stock $2.90B 4 25.0% -1.94% +1.96% View →
97 PROK ProKidney Corp. Class A Ordinary Shares $307.2M 4 35.0% -1.14% +8.42% View →
98 RGNX REGENXBIO Inc. $698.1M 4 30.0% -2.90% +2.05% View →
99 INKT MiNK Therapeutics, Inc. Common Stock $58.7M 4 41.7% -3.04% +11.47% View →
100 ALEC Alector, Inc. Common Stock $211.8M 4 10.0% -3.15% +3.21% View →

🚀 Scan for Alpha in Biological Products, (No Disgnostic Substances)

Don't trade the whole basket.
Use FILTRIX to isolate the top performing stocks among the 129 companies in this sector. Filter by MFE, Volume, and Win Rate instantly.

Find Best Setups →

📊 Biological Products, (No Disgnostic Substances) Sector Intelligence

⚡ High Volatility Sector

The Biological Products, (No Disgnostic Substances) sector (SIC 2836) aggregates data from 129 stocks. With an average Maximum Favorable Excursion (MFE) of +6.75%, this sector is highly aggressive, suited for experienced volatility traders looking for explosive moves.

📈 Statistical Expectancy

Across 3,622 analyzed alerts, the sector shows a 44.0% Win Rate with an average gain of -0.52%.

⚠️ This suggests a difficult trading environment where strict stock selection is critical. Focus on the top performers within this sector.

🏆 Sector Leader

The strongest statistical performer in this group is currently NBIX , boasting a 65.7% win rate across 14 alerts.

This significantly outperforms the sector average (44.0%), making it a primary watchlist candidate for traders seeking edge in this space.